Topline data showed that a third dose of the Pfizer-BioNTech vaccine was well tolerated among children with a safety profile similar to placebo.
The CDC is encouraging parents of children in this age group to first finish a primary vaccination series, saying only 28% now are in that category.
The proportion of overweight, obesity, or severe obesity increased from 38% to 45% among 4500 young people seen in a primary care network where most receive public insurance.
Results from a phase 2b trial showed that a bivalent RSV prefusion F protein-based vaccine was safe and led to higher neutralizing antibody responses in pregnant women.
The US FDA expanded approval of remdesivir this week to include pediatric patients aged 28 days and older, the first COVID-19 treatment indicated for this population.
How much do you know about diphtheria and the vaccine? Answer these 2 questions to find out.
SAMPLE: A 7-year-old child newly immigrated to the US has not received any previous pneumococcal vaccines. What does the CDC recommend for this child?
How can clinicians help parents of school-aged children foster wellbeing now that pediatric COVID-19 vaccination and booster doses are recommended?
How did up-to-date pediatric routine vaccination rates fare during the COVID-19 pandemic compared to before?
How do low socioeconomic status and adverse childhood experiences tie into pediatric obesity? Here, an overview for practitioners.